Dermata Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.About DRMA
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.
CEOGerald T. Proehl
CEOGerald T. Proehl
Employees8
Employees8
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees8
Employees8
DRMA Key Statistics
Market cap4.19M
Market cap4.19M
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume209.43K
Average volume209.43K
High today$0.7069
High today$0.7069
Low today$0.6539
Low today$0.6539
Open price$0.6848
Open price$0.6848
Volume60.23K
Volume60.23K
52 Week high$5.00
52 Week high$5.00
52 Week low$0.5739
52 Week low$0.5739
People also own
Based on the portfolios of people who own DRMA. This list is generated using Robinhood data, and it’s not a recommendation.